LGNZZ OTC
Ligand Pharmaceuticals, Inc.
1W: +10.8%
1M: +0.0%
3M: -41.7%
YTD: -2.8%
1Y: -51.4%
3Y: +677.8%
5Y: +438.5%
$0.07
+0.01 (+16.67%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$291M
Revenue
+54.9% YoY
$197M
Net Income
+360.0% YoY
$131M
Free Cash Flow
+125.8% YoY
96.9%
Gross Margin
13.5%
Op. Margin
76.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE22.0%
ROA12.6%
ROIC11.3%
Valuation
P/E0.0
P/B0.0
EV/EBITDA-1.3
Leverage
Debt/Equity1.16
Current Ratio30.49
Interest Cov.22.2x
Quality Scores
Piotroski F5/9
Altman Z1.47
Beneish M-1.96